Effect of late-onset epilepsy on cognitive functioning in patients with small vessel disease
Introduction
Late-onset Epilepsy (LOE), defined as epilepsy starting after 60 years of age, is an increasingly common problem in older population that accounts up to 25% of all incident cases with epilepsy [1], [2]. As life expectancy increases, with the population older than 65 years expecting to represent one in four people in Europe and Northern America by 2050, the prevalence of LOE is also expected to increase [3]. Causes of LOE include overt cerebrovascular disease, neurodegenerative disorders and dementia, traumatic brain injury, structural injury, metabolic disorders, and autoimmune diseases. However, almost 40% of patients may present LOE of an unknown etiology [3], [4].
Among several etiological hypotheses, subclinical cerebrovascular disease has been proposed to contribute to the development of a first unprovoked seizure in later life. Although it is well known that cortical vascular lesions after stroke predispose to epilepsy, cerebral small-vessel disease (cSVD) which manifests on brain parenchyma by the appearance of white matter hyperintensities, brain atrophy, and cerebral microbleeds, might also be a cause of LOE [5], [6], [7]. Moreover, the increase in blood–brain barrier permeability might trigger cSVD, resulting in structural and perivascular changes in the small vessels of the brain [8], which may in turn contribute to enhance excitability and epileptogenesis in these patients [9].
In addition, cSVD constitutes a major source of cognitive decline and neurological disability in the elderly [10]. Brain atrophy, cerebral microbleeds, lacunar infarcts, and burden of periventricular white matter lesions have been associated with steeper decline in cognitive function, specifically in executive function, attention, and information speed processing, observing a relative preservation of episodic memory encoding [11], [12]. A bidirectional association between cognitive decline and epilepsy in later life also has been established, with higher rates of prevalence of dementia in people who develop LOE and vice versa [13], [14] Although the mechanisms of this association are poorly understood, evidence suggests that patients with epilepsy present an increased relative risk (RR) of being diagnosed of Alzheimer Disease (AD) within 1 year after epilepsy onset. Interestingly, this risk is greater in those patients who had epilepsy for few years (RR of 2.5) comparing with patients who had epilepsy for more than 10 years (RR of 1.4), underpinning the idea that this increased risk is not caused by a cumulative effect of longstanding seizures [15].
All these considerations raise questions about whether epilepsy triggers pathological changes in the brain that may increase the likelihood of dementia; or if epilepsy and cognitive decline may be the expression of shared pathological mechanisms [16], as cerebrovascular disease may be the shared contributor to both dementia and epilepsy [17], [18].
Although increasing evidence associates cSVD, vascular risk factors, LOE and neurocognitive decline, no group studied the interplay between these factors thus far. Hence, we have set a retrospective cross-sectional study aimed to explore how unprovoked epileptic seizures along with vascular-related factors contribute to neurocognitive impairments in patients with cSVD.
Section snippets
Participants
In this study, we followed the setting previously defined for patients with LOE [17], and included those patients aged ≥ 60 years and at least one unprovoked epileptic seizure with no evidence of potential epileptogenic lesions in MRI. Therefore, we recruited patients with seizures and incidental diagnosis of cSVD during MRI evaluation (cSVD-LOE group), based on radiological markers on brain MRI defined as: subcortical microbleeds, white matter hyperintensities (Fazekas score ≥ 1) or at least 1
Sociodemographic and clinical characteristics of the sample
Twenty-seven patients were included in both cSVD and cSVD-LOE groups (18 males; 9 females). We observed no differences between groups in sociodemographic variables. In the cSVD-LOE group, temporal lobe epilepsy was the most common form of focal epilepsy (51.9% of patients), followed by frontal lobe epilepsy (14.8%). Generalized epilepsy and other undetermined epilepsies accounted for 33.3% of the sample. In the cSVD-LOE group neurocognitive assessments were performed 2.27 ± 2.63 years after
Discussion
This study aimed to explore the effect of epilepsy and vascular variables on cognitive performance in patients who had cerebral small vessel disease. Our results show that patients in the cSVD-LOE group exhibited a poorer performance on measures of memory, attention and executive functions, and the presence of epilepsy – but not specifically the localization of seizures – was the major contributor to a decline in verbal memory functioning. To our knowledge, this is the first study comparing
Competing interests
None of the authors has any conflict of interests to disclose. This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
References (42)
Epilepsy in the elderly: scope of the problem
Int Rev Neurobiol
(2007)- et al.
Prevalence and subtypes of radiological cerebrovascular disease in late-onset isolated seizures and epilepsy
Clin Neurol Neurosurg
(2013) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
Lancet Neurol
(2010)- et al.
Epileptic activity in Alzheimer's disease: causes and clinical relevance
Lancet Neurol
(2017) - et al.
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Lancet Neurol
(2013) - et al.
Alzheimer’s disease neuroimaging initiative. Fractioning verbal episodic memory in Alzheimer’s disease
Neuroimage
(2011) - et al.
Structural and physiological MRI correlates of occult cerebrovascular disease in late-onset epilepsy
Neuroimage Clin
(2015) - et al.
Cerebrovascular disease burden in late-onset non-lesional focal epilepsy
Seizure
(2019) - et al.
Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance
Neuroimage Clin
(2015) - et al.
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?
Neurobiol Aging
(2016)